[
  {
    "ts": "2025-12-01T13:30:00+00:00",
    "headline": "Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States",
    "summary": "MENLO PARK, Calif., December 01, 2025--Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson’s disease, today announced a strategic collaboration with Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, to make the OctaveⓇ Multiple Sclerosis Disease Activity (MSDA) Test accessible through Quest’s nationwide specimen-collection network.",
    "url": "https://finance.yahoo.com/news/octave-bioscience-forms-strategic-collaboration-133000086.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "043b39a3-7f54-3d59-b2fb-049c1c943191",
      "content": {
        "id": "043b39a3-7f54-3d59-b2fb-049c1c943191",
        "contentType": "STORY",
        "title": "Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the United States",
        "description": "",
        "summary": "MENLO PARK, Calif., December 01, 2025--Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson’s disease, today announced a strategic collaboration with Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, to make the OctaveⓇ Multiple Sclerosis Disease Activity (MSDA) Test accessible through Quest’s nationwide specimen-collection network.",
        "pubDate": "2025-12-01T13:30:00Z",
        "displayTime": "2025-12-01T13:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/b21b8b8d9040a598fd4ef791d12487ac",
          "originalWidth": 480,
          "originalHeight": 278,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mqg7MIxAWE9HS6r9RngTEA--~B/aD0yNzg7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b21b8b8d9040a598fd4ef791d12487ac.cf.webp",
              "width": 480,
              "height": 278,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6b2jE94WdkSteRw5DluU1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/b21b8b8d9040a598fd4ef791d12487ac.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/octave-bioscience-forms-strategic-collaboration-133000086.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/octave-bioscience-forms-strategic-collaboration-133000086.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DGX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]